High Risk Lesions

High risk lesions such as atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH) and LCIS (lobular carcinoma in situ) or lobular neoplasia when identified on a needle biopsy are often followed by an open excisional biopsy as there is a 10-20% incidence of an associated cancer.

Patients can be offered chemopreventive agents such as tamoxifen or raloxifene. However, most women are generally followed twice a year with physical examinations and annual mammograms. High risk lesions such as atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH) and LCIS (lobular carcinoma in situ) or lobular neoplasia when identified on a needle biopsy are often followed by an open excisional biopsy as there is a 10-20% incidence of an associated cancer.

Patients can be offered chemopreventive agents such as tamoxifen or raloxifene. However, most women are generally followed twice a year with physical examinations and annual mammograms.